RNA sequencing (RNA-seq) and H3K27ac chromatin immunoprecipitation sequencing (ChIP-seq) experiments in basal-like cell lines with FOXD1 knockdown revealed that FOXD1 maintains distinct enhancer-gene programs associated with tumor progression. This evidence concerns the gene FOXD1 and neoplasm.